Exploration the Therapeutic Mechanism of Ba-Duan-Jin in the Treatment of Fibromyalgia by Improving Gut Microbiota and Brain Magnetic Resonance Imaging

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To investigate the mechanism by Ba-Duan-Jin in the treatment of fibromyalgia. Twenty eligible fibromyalgia patients were selected, and were trained and guided online by an experienced Ba-Duan-Jin instructor with reference to the standard operating procedure (SOP) for a 12-week course of 1 hour twice a week. The evaluation points were 0, 4, 8, and 12 weeks. The change of pain Visual Analogue Score (VAS) and tener point count (TPC) post-treatment were evaluated. And blood, feces, and brain fMRI were collected from the patients at 0 and 12 weeks to compare the changes in gut microbiota, metabolites, and brain function networks before and after the intervention with the 16SrRNA sequencing, targeted metabolomics, and real-time Quantitative Polymerase Chain Reaction (PCR).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

• Meet the 1990 American College of Rheumatology (ACR) Research Classification Criteria for fibromyalgia or 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria;

• Be over 18 years of age;

• Female;

• Right-handedness;

• Sign informed consent.

Locations
Other Locations
China
Guang'anmen Hospital
RECRUITING
Beijing
Contact Information
Primary
Shiya Wu, MD
2778823398@qq.com
+86 010-88001060
Backup
Juan Jiao, PhD
jiao.juan@hotmail.com
+86 010-88001060
Time Frame
Start Date: 2024-01-31
Estimated Completion Date: 2024-06-30
Participants
Target number of participants: 40
Treatments
Experimental: Ba-Duan-Jin group
The participants will be trained and guided online by an experienced Ba-Duan-Jin instructor with reference to the standard operating procedure (SOP) for a 12-week course of 1 hour twice a week.
No_intervention: Healthy control group
Related Therapeutic Areas
Sponsors
Leads: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

This content was sourced from clinicaltrials.gov